Thalassemia minor

Summary

Thalassemia minor (MONDO:0044210) is a disease and 2 clinical trials. A subtype of beta-thalassemia HBB/LCRB — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	thalassemia minor
Mondo ID	MONDO:0044210
DOID	DOID:0080774
ICD-10-CM	D56.3
SNOMED CT	19442009
UMLS	C0869532
MedGen	450549
GARD	0025885
MedDRA	10054662
Is cancer (heuristic)	no

Also known as: beta thalassemia trait

Disease family

This is a subtype of beta-thalassemia HBB/LCRB. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › inherited hemoglobinopathy › thalassemia › beta thalassemia › beta-thalassemia HBB/LCRB › thalassemia minor

Related subtypes (2): beta-thalassemia major, beta-thalassemia intermedia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02428023	Not specified	UNKNOWN	B-Thalasaemia Trait and Its Possible Cardioprotective Role
NCT05960214	Not specified	COMPLETED	Cardiac Management of Patients With Thalassemia Minor and Breast Cancer